{"id":"W4393252428","doi":"10.1200/jco.23.02329","title":"Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia; McGill University; Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Clinical endpoint; Internal medicine; Phases of clinical research; Clinical trial; Lymphoma; Non-Hodgkin's lymphoma; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006456516,0.0002295962,0.001977196,0.0006359733,0.0000473355,0.00001919983,0.000220453,0.0003766549,0.0004983637],"category_scores_gemma":[0.003002173,0.0001511115,0.0003297277,0.0004782333,0.000413403,0.000132049,0.0001353273,0.001759235,0.000005866056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003856685,"about_ca_system_score_gemma":0.004854974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007191792,"about_ca_topic_score_gemma":0.0001461963,"domain_scores_codex":[0.9946485,0.001234019,0.002536326,0.0003909799,0.0008215387,0.0003686803],"domain_scores_gemma":[0.9923086,0.005081413,0.001375712,0.0003437573,0.0004634005,0.0004270989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3023654,0.03589046,0.02828211,0.0003146096,0.001546661,0.0432778,0.00561317,0.00001131129,0.03171798,0.00001409261,0.0026275,0.5483389],"study_design_scores_gemma":[0.2646047,0.57933,0.1073267,0.002486593,0.001117743,0.003667821,0.006542222,0.0007877222,0.003403023,0.0002634081,0.03008101,0.0003890442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920761,0.003641344,0.00001708077,0.001212478,0.0007262353,0.0007353729,0.000006067928,0.00001115945,0.001574163],"genre_scores_gemma":[0.9923878,0.002029613,0.0005167757,0.0002178791,0.0003756445,0.00001811763,0.000001239056,0.0000431941,0.004409718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5479499,"threshold_uncertainty_score":0.8612515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08335546380125415,"score_gpt":0.4715924011792489,"score_spread":0.3882369373779948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}